Drug Trial News

RSS

Men and women who were overweight in young adulthood and middle age have significantly higher Medicare costs in older age

According to background information, obesity is associated with increased risk of high blood pressure, diabetes, and certain cancers, and has been identified as a major risk factor for coronary heart disease (CHD).

8 Dec 2004

Breast MRI moderately useful for detecting breast cancer

In women with breast lesions that are suspicious for cancer, based on clinical examination or mammography, performing a breast MRI has high sensitivity but only moderate specificity for detecting breast cancer, but does not necessarily eliminate the need for tissue sampling, according to a study in the December 8 issue of JAMA.

8 Dec 2004

Mexican Americans and non-Hispanic Whites born in the United States have a higher risk for developing psychiatric disorders

According to the results of a National Institutes of Health (NIH) study, reported in the December issue of the Archives of General Psychiatry, Mexican Americans and non-Hispanic Whites born in the United States have a higher risk for developing psychiatric disorders than their foreign-born counterparts who have immigrated to the United States.

7 Dec 2004

Zarnestra, a farnesyl transferase inhibitor, can help treat high-risk myelodysplastic syndrome patients

An oral targeted therapy gentle enough to be used by patients in their 70s or 80s is showing benefit in treating high-risk myelodysplastic syndrome (MDS), a pre-leukemic disorder that can progress to acute myelogenous leukemia (AML), according to a study presented at the annual meeting of the American Society of Hematology (ASH).

7 Dec 2004

Revlimid clinical data in newly diagnosed multiple myeloma presented

Celgene Corporation announced today that data evaluating clinical results on Revlimid (lenalidomide) as a new therapeutic approach for patients with newly diagnosed multiple myeloma (MM) was presented at the American Society of Hematology 46th Annual Meeting in San Diego.

7 Dec 2004

Combination of thalidomide and dexamethasone may be a promising treatment for multiple myeloma

The combination of two pills -- thalidomide and dexamethasone -- may be an effective alternative to the intravenous chemotherapy commonly prescribed to patients with multiple myeloma, according to a large collaborative study conducted by the Eastern Cooperative Oncology Group and led by a Mayo Clinic investigator.

7 Dec 2004

Study looks at muscle repair and resilience

Healthy military personnel and muscular dystrophy patients are at opposite ends of the spectrum when is comes to muscle strength and resilience. However, a new University of Iowa study may provide insights that improve muscle health for both these groups.

7 Dec 2004

Measuring bone marrow fat can better predict weakening of bones

BMD measurement with DEXA is presently the most commonly used parameter for determining bone weakening. Researchers have long questioned whether there may be other measurable bone components that influence mechanical stability of bone.

7 Dec 2004

Magnetism does not cause paranormal experiences

Previous research has shown that paranormal experiences can be achieved via electromagnetic stimulation of the temple lobe. Now scientists from Uppsala and Lund universities in Sweden are calling into question how the experiments were set up and therefore questioning the results.

7 Dec 2004

Thalidomide shows promise in fighting myeloma

Thalidomide, a drug often used to treat symptoms of leprosy and in testing to fight HIV, is now demonstrating activity in fighting a common cancer that occurs in bone marrow, myeloma.

6 Dec 2004

Study on methylisothiazolinone in shampoo lacks a credible scientific basis

Consumers can rest assured that their cosmetic products, including shampoos, are safe. The abstract on Methylisothiazolinone (MI), presented at the Cell Biology 2004 meeting of the American Society for Cell Biology, lacks a credible scientific basis in suggesting that MI could be a safety issue for consumers using personal care products.

6 Dec 2004

Cognitive behaviour therapy helps adolescents with chronic fatigue syndrome

Psychological support, in the form of cognitive behaviour therapy, is an effective treatment for adolescents with chronic fatigue syndrome, finds a new study published on bmj.com today.

6 Dec 2004

Month of birth linked to risk of multiple sclerosis

In the northern hemisphere, being born in May is linked to an increased risk of developing multiple sclerosis later in life, while being born in November carries the lowest risk, finds a new study published on bmj.com today.

6 Dec 2004

Majority of hospitalizations for asthma may be the result of people not taking their inhaled steroid medications

Inhaled steroids have become the standard in the treatment of persistent asthma. They have been shown to significantly improve asthma symptoms and reduce asthma complications. However, adherence to the prescribed inhaled steroids is poor among adult asthma patients.

6 Dec 2004

Self-confidence workshops improve depressive symptoms

Self-confidence workshops improve depressive symptoms, distress and self-esteem significantly, according to a study published in the December issue of the British Journal of Psychiatry.

6 Dec 2004

Mental disorders and suicide attempts are caused by social factors

Findings from a new study from Australia suggest that mental disorders and suicide attempts are caused by social factors. There is a need for social and economic responses beyond provision of mental health services.

6 Dec 2004

Family history not age greatly affects breast cancer risk

CancerBACUP has published the results of a survey revealing that more over 50s believe that family history - not age - greatly affects breast cancer risk.

6 Dec 2004

Common ingredient in some shampoos (methylisothiazolinone) stunts developing neurons of rats

An antimicrobial agent found in some shampoos and hand creams and widely used in industrial settings inhibits the development of particular neuron structures that are essential for transmitting signals between cells.

6 Dec 2004

Two recent studies are souring milk's image among health authorities

Two recent studies are souring milk's image among health authorities. One, published in the November issue of the American Journal of Clinical Nutrition, shows that women who consume two or more glasses of milk a day have twice the risk of a certain form of ovarian cancer than those who rarely or never consume milk.

6 Dec 2004